CAR T-Cell Therapy is a revolutionary cancer treatment that empowers the patient’s own immune system to fight cancer. The procedure is effective by modifying the patient’s T-cells to express chimeric antigen receptors (CARs), allowing the immune system to identify and destroy cancer cells. CAR T-cell treatment, which was initially developed for blood cancers such as leukemia and lymphoma, is showing promising outcomes, even in patients who have not responded to traditional treatments.
India has emerged as the premier destination for CAR T-cell therapy, offering advanced treatment at significantly lower costs than Western countries, without compromising quality or outcome.
✅ FDA-approved therapies (Kymriah, Yescarta, Tecartus, Abecma, Carvykti) now available
✅ Effective in treating relapsed or refractory B-cell cancers
✅ Personalized, one-time treatment with long-term remission potential
✅ Shorter recovery time compared to chemotherapy or bone marrow transplant
✅ Access to top hospitals and CAR T-cell therapy specialists in India
Patients with relapsed or refractory blood cancers such as B-cell acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (DLBCL)
Cancers expressing specific antigens targeted by CARs (e.g., CD19)
Those who failed 2+ prior lines of treatment (chemotherapy, radiation, etc.)
Patients in generally good health, without severe organ dysfunction or active infections
Severe heart, liver, or kidney dysfunction
Active or uncontrolled infections
Certain neurological or autoimmune conditions
Poor performance status or inability to tolerate lymphodepletion chemotherapy
Leukapheresis – Collection of patient’s T-cells
Genetic Modification – Engineering CAR into the T-cells
Expansion – Culturing T-cells to desired quantity
Lymphodepletion – Pre-infusion chemotherapy to prepare the body
CAR T-Cell Infusion – T-cells reintroduced intravenously
Monitoring – Observation for side effects like CRS or neurotoxicity
We believe that great care starts with trust. That’s why we ensure complete transparency in our treatment pricing—no surprises, no hidden fees, just honest and clear costs for the care you deserve.
| Type of FDA Approved CAR T-Cell Therapy in India | Diagnosed | Cost in USD | ||
|---|---|---|---|---|
| Kymriah | B-Cell Acute Lymphoblastic Leukemia (ALL) vs. B-Cell Non-Hodgkin’s Lymphoma (NHL) | $65,000 – $85,000 | ||
| Yescarta |
| $65,000 – $85,000 | ||
| Tecartus | Mantle Cell Lymphoma, B-cell ALL | $65,000 – $85,000 | ||
| Breyanzi | B-cell NHL | $65,000 – $85,000 | ||
| Abecma | Multiple Myeloma | $45,000 – $65,000 | ||
| Carvykti | Multiple Myeloma | $45,000 – $65,000 |
CAR T-cell production
Lab tests and pathology
Infusion and hospital care
Oncologist consultations
Airport pickup and drop
International & domestic travel
Hotel and accommodation outside hospital
Additional device calibration or follow-ups
Post-operative physiotherapy or psychiatric care
Management of complications or unrelated conditions
India has emerged as a global leader in CAR-T Cell Therapy due to several key advantages:
Affordable treatment without compromising quality
Access to FDA-approved therapies and advanced labs
Highly experienced oncologists and haematologists
State-of-the-art hospitals in Delhi, Mumbai, Chennai, and Hyderabad
Multilingual support for international patients
Fast-track medical visa and coordinated travel assistance by HOSPISITY
🩺 Trusted Medical Travel Partner – End-to-end patient support
👨⚕️ Access to Top Cancer Centres – Handpicked specialists in CAR-T Cell Therapy
🏥 Global Hospital Network – Leading hospitals in India and Turkey
💬 Personalized Case Handling – Dedicated HRE (Hospisity Relationship Executive)
📞 Free teleconsultation before arrival and post-treatment follow-up
Research is ongoing, but current approvals are primarily for blood cancers.
The most common are cytokine release syndrome (CRS), fever, fatigue, and neurological effects, which are manageable under expert care.
Hospital stay may last up to 25 days, with full recovery and observation extending up to 60 days post-treatment.
Some CAR T-cells persist as memory cells, potentially offering long-term immunity.
Yes. HOSPISITY offers complete assistance including visas, appointments, hospital coordination, and accommodation.
Top JCI Accredited Hospitals centers in Delhi, Mumbai, Chennai, Hyderabad, and Bangalore offer CAR-T Cell Therapy,
Director - Medical Oncology, Hematology, BMT & Cellular Therapy
Apollo Proton Cancer Centre,Chennai
Oncology | Medical Oncology
35+ Years Experience
Head of the Department & Senior Consultant Medical Oncology
Shalby Sanar International Hospital
Oncology | Medical Oncology
10+ Years Experience
Director - Haemato-oncology and Bone Marrow Transplant
BLK-Max Super Speciality Hospital,Delhi
Haematology | Haemato-Oncology| Bone Marrow Transplant
18+ Years Experience
Principal Director & Chief - Hematology, Hemato Oncology & Bone Marrow Transplant
Fortis Memorial Research Institute,Gurugram
Haematology | Haemato-Oncology| Bone Marrow Transplant
15+ Years Experience
We believe that great care starts with trust. That’s why we ensure complete transparency in our treatment pricing—no surprises, no hidden fees, just honest and clear costs for the care you deserve.
